Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by WALTERS, N.
Right arrow Articles by CALNE, D. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by WALTERS, N.
Right arrow Articles by CALNE, D. B.
NEUROLOGY 1976;26:1008
© 1976 American Academy of Neurology

Penicillin transport from cerebrospinal fluid

N. WALTERS, P. F. TEYCHENNE, M.D., L. E. CLAVERIA, M.D. and D. B. CALNE, D.M.

From the Royal Postgraduate Medical School, London, England, and the National Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Department of Health, Education, and Welfare, Bethesda, Maryland.

The passage of penicillin G from cerebrospinal fluid (CSF) was studied by continuous ventriculocisternal perfusion in conscious rabbits. The concentration of penicillin G in the perfusate, collected from the cisterna magna, was 76.5 percent ± 1.0 (SEM) of that entering the ventricles (having adjusted for normal secretion of CSF). The mean concentration of penicillin G rose 15 percent (p < 0.005) in the cisternal CSF after probenecid (2 mg per milliliter) was added to the perfusion fluid. We conclude that an active transport system removes penicillin G from the CSF; this mechanism can be inhibited by intraventricular probenecid. Our results are in accord with observations deriving from studies on anesthetized animals given probenecid intravenously or intraperitoneally.

Requests for reprints should be addressed to Dr. Calne, Bldg. 10, Rm 6D20, National Institute of Health, Bethesda MD 20014.

Received for publication January 16, 1976.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1976 by AAN Enterprises, Inc.